271. Ankylosing spondylitis Clinical trials / Disease details
Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146
Showing 1 to 10 of 16 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ITMCTR2200006601 | 2022-09-15 | 2022-09-15 | Observation of curative effect of Du-moxibustion on patients with active ankylosing spondylitis | Clinical evaluation and mechanism study of moxibustion on Du meridian in the treatment of active ankylosing spondylitis Clinical evaluation and mechanism study of moxibustion on Du meridian in the treatment of active ank ... | ankylosing spondylitis | healthy group:Oral celecoxib;therapy group:Du-Moxibustion (Moxibustion of Governor Vessel); | Affiliated Hospital of Shandong University of Traditional Chinese Medicine | NULL | Recruiting | 18 | 60 | Both | healthy group:30;therapy group:30; | China | |
2 | ChiCTR2100052323 | 2021-10-28 | 2021-10-24 | The treatment of Ankylosin Spondylitis by Bushenqiangduqinghuatang: A randomized controlled clinical trial The treatment of Ankylosin Spondylitis by Bushenqiangduqinghuatang: A randomized controlled clinical ... | The treatment of Ankylosin Spondylitis by Bushenqiangduqinghuatang: A randomized controlled clinical trial The treatment of Ankylosin Spondylitis by Bushenqiangduqinghuatang: A randomized controlled clinical ... | ankylosing spondylitis | treatment group:Bushenqiangduqinghuatang and celecoxib;Control group :celecoxib; | China-Japan Friendship Hospital | NULL | Recruiting | 16 | ? | Both | treatment group:41;Control group :41; | China | |
3 | ITMCTR2100004572 | 2021-03-09 | 2021-03-14 | Study on the effect of ginger with different thickness on the treatment of ankylosing spondylitis | Effect of Fuyang and Dumoxibustion on Ankylosing Spondylitis of Kidney-Yang Deficiency and on TNF-a and IL-6 Effect of Fuyang and Dumoxibustion on Ankylosing Spondylitis of Kidney-Yang Deficiency and on TNF-a ... | Ankylosing spondylitis | Thick ginger du moxibustion group:Oral celecoxib 20mg once a day, combined with Du moxibustion (ginger 5cm thickness);The control group:Celecoxib 20mg once daily;Ginger tube moxibustion group:Oral celecoxib 20mg once a day, combined with Du moxibustion (ginger thickness 3cm); Thick gingerdu moxibustion group:Oral celecoxib20mg once a day, combined with Du moxibustion (ginger ... | Affiliated Hospital of Nanjing University of Chinese Medicine | NULL | Recruiting | 18 | 60 | Male | Thick ginger du moxibustion group:20;The control group:20;Ginger tube moxibustion group:20; | China | |
4 | ChiCTR2100044284 | 2021-03-09 | 2021-03-14 | Study on the effect of ginger with different thickness on the treatment of ankylosing spondylitis | Effect of Fuyang and Dumoxibustion on Ankylosing Spondylitis of Kidney-Yang Deficiency and on TNF-a and IL-6 Effect of Fuyang and Dumoxibustion on Ankylosing Spondylitis of Kidney-Yang Deficiency and on TNF-a ... | Ankylosing spondylitis | The control group:Celecoxib 20mg once daily;Ginger tube moxibustion group:Oral celecoxib 20mg once a day, combined with Du moxibustion (ginger thickness 3cm);Thick ginger du moxibustion group:Oral celecoxib 20mg once a day, combined with Du moxibustion (ginger 5cm thickness); The control group:Celecoxib20mg once daily;Gingertube moxibustion group:Oral celecoxib20mg once a da ... | Affiliated Hospital of Nanjing University of Chinese Medicine | NULL | Recruiting | 18 | 60 | Male | The control group:20;Ginger tube moxibustion group:20;Thick ginger du moxibustion group:20; | China | |
5 | ITMCTR2100004334 | 2021-02-01 | 2021-01-28 | Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and We ... | Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and We ... | Ankylosing Spondylitis | integrated traditional Chinese and western medicine:Bushen-Qiangdu-Zhilv decoction and Celecoxib Capsules; integrated traditional Chinese and western medicine:Bushen-Qiangdu-Zhilv decoction and CelecoxibCaps ... | Guangdong Provincial Hospital of Chinese Medicine | NULL | Recruiting | 18 | 70 | Both | integrated traditional Chinese and western medicine:27; | China | |
6 | ChiCTR2100042789 | 2021-02-01 | 2021-01-28 | Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and We ... | Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and We ... | Ankylosing Spondylitis | integrated traditional Chinese and western medicine:Bushen-Qiangdu-Zhilv decoction and Celecoxib Capsules; integrated traditional Chinese and western medicine:Bushen-Qiangdu-Zhilv decoction and CelecoxibCaps ... | Guangdong Provincial Hospital of Chinese Medicine | NULL | Recruiting | 18 | 70 | Both | integrated traditional Chinese and western medicine:27; | China | |
7 | ChiCTR2000034142 | 2019-04-01 | 2020-06-26 | Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabolomics Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ... | Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabolomics Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ... | Ankylosing spondylitis | Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group 2:Take Chinese medicine preparation modified Wen-Shen Juan-Bi-Tang orally;NSAID:Take celecoxib orally; Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group ... | Jiangsu Province Hospital of TCM | NULL | Pending | 25 | 70 | Both | Experimental group:40;Experimental group 2:40;NSAID:40; | N/A | China |
8 | ITMCTR2000003433 | 2019-04-01 | 2020-06-26 | Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabolomics Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ... | Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabolomics Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ... | Ankylosing spondylitis | Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group 2:Take Chinese medicine preparation modified Wen-Shen Juan-Bi-Tang orally;NSAID:Take celecoxib orally; Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group ... | Jiangsu Province Hospital of TCM | NULL | Pending | 25 | 70 | Both | Experimental group:40;Experimental group 2:40;NSAID:40; | N/A | China |
9 | NCT03473665 (ClinicalTrials.gov) | March 1, 2018 | 13/3/2018 | Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis | Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis: a Pilot Study | Ankylosing Spondylitis;Axial Spondyloarthritis | Drug: Indomethacin;Drug: Diclofenac;Drug: Meloxicam;Drug: Celecoxib | Columbia University | NULL | Terminated | 18 Years | N/A | All | 9 | Phase 4 | United States |
10 | NCT02758782 (ClinicalTrials.gov) | September 2016 | 20/4/2016 | NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage i ... | COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy ... | Ankylosing Spondylitis | Biological: Golimumab;Drug: Celecoxib | Charite University, Berlin, Germany | NULL | Completed | 18 Years | N/A | All | 156 | Phase 4 | Germany |